| Westmont College, BA |
Eric Grinstead is responsible for commercial and business operations at Synageva. Eric brings over twenty years of experience in the biopharmaceutical industry with responsibilities spanning operations, market access, sales, marketing, reimbursement, government affairs at companies including Alexion, Genzyme, Amgen and GSK. More specifically, his experience includes: pricing, health economics, distribution, payor segments, channel segments, specialty networks, policy, patient and alliance management, patient assistance programs and commercial operations for rare and ultra-rare diseases in both the United States as well as ex-US regions. Eric was most recently a member of Alexion’s management team as Vice President of Government Affairs and Market Access, where his efforts with the commercial functions helped to support the highly successful launch of Soliris. He also held responsibilities for the patient and policy communities and helped to lay the foundation for Alexion’s global government affairs. At Genzyme, Eric was responsible for leading the patient and product services group for the lysosomal storage diseases franchise. Before Genzyme, Eric worked for Amgen with responsibilities for the brand economics in rheumatology and anemia business units and state government affairs for all brands. Eric earned a BA (cum laude) from Westmont College, Santa Barbara, CA.
